Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$196M |
| 2 |
Verizon
VZ
|
+$166M |
| 3 |
Edison International
EIX
|
+$152M |
| 4 |
PPL
PPL Corp
PPL
|
+$122M |
| 5 |
Estee Lauder
EL
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ameren
AEE
|
+$140M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$136M |
| 3 |
ANDV
Andeavor
ANDV
|
+$111M |
| 4 |
LyondellBasell Industries
LYB
|
+$105M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.77% |
| 2 | Energy | 13.48% |
| 3 | Utilities | 8.99% |
| 4 | Financials | 8.47% |
| 5 | Consumer Discretionary | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLD
476
DELISTED
Cloud Peak Energy Inc
CLD
| $18.8M | 0.05% |
+889,845
| New | +$16.7M |
|
|
HZNP
477
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $18.8M | 0.05% |
1,240,806
+344,195
| +38% | +$3.89M |
|
478
Align Technology
ALGN
$11.5B
| $18.8M | 0.05% |
362,034
+289,906
| +402% | +$16.2M |
|
479
CALL
Amgen
AMGN
$238B
| $18.6M | 0.05% |
150,900
+70,100
| +87% | +$8.5M |
|
|
DTV
480
DELISTED
DIRECTV COM STK (DE)
DTV
| $18.6M | 0.05% |
243,390
+28,183
| +13% | +$2.07M |
|
481
Salesforce
CRM
$171B
| $18.5M | 0.05% |
324,804
-64,465
| -17% | -$3.85M |
|
|
RSPP
482
DELISTED
RSP Permian, Inc.
RSPP
| $18.5M | 0.05% |
+641,851
| New | +$16.1M |
|
483
Boeing
BA
$169B
| $18.5M | 0.05% |
147,502
-182,103
| -55% | -$23.7M |
|
|
LVLT
484
DELISTED
Level 3 Communications Inc
LVLT
| $18.5M | 0.05% |
471,431
+160,945
| +52% | +$5.79M |
|
485
Alcoa
AA
$13.7B
| $18.4M | 0.05% |
595,839
+115,380
| +24% | +$3.21M |
|
|
NUVA
486
DELISTED
NuVasive, Inc.
NUVA
| $18.4M | 0.05% |
479,714
+325,177
| +210% | +$11.9M |
|
487
PUT
Targa Resources
TRGP
$64.1B
| $18.4M | 0.05% |
185,600
+182,100
| +5,203% | +$17M |
|
488
GSK
GSK
$105B
| $18.4M | 0.05% |
274,854
-1,759
| -0.6% | -$119K |
|
489
Chevron
CVX
$403B
| $18.4M | 0.05% |
154,328
-288,617
| -65% | -$33.6M |
|
490
Delek US
DK
$4.38B
| $18.3M | 0.05% |
631,314
+430,958
| +215% | +$13M |
|
491
Cognizant
CTSH
$27.9B
| $18.3M | 0.05% |
361,669
+309,295
| +591% | +$15.5M |
|
492
Liberty Global Class C
LBTYK
$3.55B
| $18.3M | 0.05% |
554,120
-149,377
| -21% | -$4.99M |
|
|
DATA
493
DELISTED
Tableau Software, Inc.
DATA
| $18.2M | 0.05% |
239,206
-153,537
| -39% | -$12.9M |
|
|
CSC
494
DELISTED
Computer Sciences
CSC
| $18.1M | 0.05% |
707,667
+605,028
| +589% | +$15.2M |
|
|
TRAK
495
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
| $18.1M | 0.05% |
368,476
+353,953
| +2,437% | +$17.8M |
|
496
Mueller Water Products
MWA
$3.89B
| $18.1M | 0.05% |
1,901,500
-433,204
| -19% | -$3.98M |
|
497
PUT
Berkshire Hathaway Class B
BRK.B
$1.06T
| $18.1M | 0.05% |
+144,500
| New | +$16.9M |
|
498
Pacific Biosciences
PACB
$420M
| $17.9M | 0.05% |
3,353,536
+907,389
| +37% | +$5.74M |
|
499
United Therapeutics
UTHR
$22B
| $17.9M | 0.05% |
190,363
+2,044
| +1% | +$209K |
|
500
PUT
iShares China Large-Cap ETF
FXI
$4.28B
| $17.9M | 0.05% |
+500,000
| New | +$17.5M |
|
Similar funds
Israel Englander's Q1 2014 Portfolio in Review
As of Q1 2014, Israel Englander held 4,356 positions worth $34.5B, up 8.9% from $31.7B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Israel Englander deployed $1.49B of net new capital in Q1 2014, opening 945 new positions and adding to 1,266 existing holdings. Its largest new stake was Bausch Health: 575,504 shares worth $75.9M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Energy and Utilities.
On the sell side, the largest reduction was Ameren, an estimated $140M trimmed.
- Israel Englander's largest Q1 2014 buy was Bausch Health: 575,504 shares worth $75.9M.
- Israel Englander added most to Devon Energy in Q1 2014, an estimated $196M increase.
- Israel Englander's biggest Q1 2014 reduction was Ameren, cutting an estimated $140M.
- Israel Englander fully exited PepsiCo in Q1 2014, selling an estimated $89.1M.
- Israel Englander's ten largest holdings make up 7.9% of its $34.5B portfolio in Q1 2014.
- Israel Englander opened 945 new positions and closed 958 in Q1 2014.
- Israel Englander's portfolio value rose 8.9% quarter-over-quarter to $34.5B.
Based on Millennium Management's 13F filing for Q1 2014, filed 15 May 2014.